Macada Holding, Inc. (PINKSHEETS: MCDA) announced that management has completed negotiations on three Marketing and distribution agreements with Lyfetec, Inc for their Bio-Skin products. The company plans are to acquire other medical product companies and their assets into the company's subsidiary Lyfetec, Inc.

Macada Management also has completed the Lyfetec - Pembrook Gun Range and Macada's financials and disclosure statement and placed them on the Pink Sheets. "We have been working diligently to improve the company structure and position to become a profitable company for shareholder value. We intend to double the company's revenue by the end of the 4th quarter," said Ron Ritter and Steven Cohen, MCDA's CEO and President. "The Company is now in the process of finalizing definitive agreements to acquire the supplement products," he continued. "To this end, we will increase the transparency of the company through public disclosure and the posting of financial statements of the new company structure."

Lyfetec's continued focus will be in the manufacturing of the Bio-Skin line, launching this month's Internet sales with the first two: eye cream and serum.

Pembroke has recently remodeled a new teaching facility and calibrated all the lanes in the range for better accuracy. Ron will focus in the sporting goods industry and the new AMMO manufacturing plant this month.

Macada will announce each deal upon completion of any closing.

Lyfetc, Inc. also announces, as of today that the company is exploring the opportunity of its second "clinical" product line. "We presently have several professional relationships in the United States and internationally for distribution and interest with three companies in global private branding licenses and distribution rights with their product lines," said Mr. Cohen. "More information will be released subsequent to any changes."

Safe Harbor Provision

This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties and events that may be beyond the control of Macada Holding, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, the availability of technical personnel, changes in technology and competition.

Contact: Ron Ritter 954-782-2056

KMA (CE) (USOTC:MCDA)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more KMA (CE) Charts.
KMA (CE) (USOTC:MCDA)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more KMA (CE) Charts.